The results of large-scale alliance centralized procurement have been intensively implemented, and the price reduction of consumables is becoming more and more "national".
Jiangxi and Guizhou have implemented the results of multiple alliance centralized procurement
On May 31, the Jiangxi Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Selected Results of the Centralized Procurement of Six Types of Medical Consumables such as Hemodialysis" and "Notice on the Implementation of the Selected Results of the Interprovincial Alliance of Centralized Procurement of Kidney Function and Cardiac Enzyme Biochemical Detection Reagents".
According to the notice, the results of the centralized procurement of Henan Alliance hemodialysis, Inner Mongolia Alliance hemostatic materials, Zhejiang Alliance coronary intravascular ultrasound diagnostic catheters and infusion pumps, Shaanxi Alliance dural (spinal) membrane mesh and hernia repair materials, as well as Jiangxi-led renal function and cardiac enzyme reagents, will be implemented in Jiangxi on July 1.
The results of each category are as follows
Among them, the procurement cycle of hemostatic materials and hemodialysis medical consumables is 1 year; The procurement cycle of medical consumables, renal function and cardiac enzyme biochemical detection reagents for dura (spinal) membrane patches and hernia repair materials, is 2 years; The centralized procurement cycle of coronary intravascular ultrasound diagnostic catheters and infusion pumps is 3 years.
The agreed purchase volume of each category is as follows:
On the same day, the Guizhou Public Resources Trading Network issued the "Notice of the Provincial Medical Insurance Bureau on Doing a Good Job in the Implementation of the Selected Results of the Centralized Procurement of Coronary Intravascular Ultrasound Diagnostic Catheters and Infusion Pumps" and the "Notice of the Provincial Medical Insurance Bureau on Doing a Good Job in the Implementation of the Selected Results of the Centralized Procurement of Medical Consumables for Hemostatic Materials".
The above-mentioned results of the above-mentioned Zhejiang Alliance coronary intravascular ultrasound diagnostic catheters and infusion pumps, and Inner Mongolia Alliance hemostatic materials centralized procurement will also be implemented in Guizhou on June 20, 2024.
Recently, the centralized procurement of major alliances has entered an intensive implementation period, and the above-mentioned consumables are summarized as follows:
New trend of consumables centralized procurement:
Nationwide joint procurement, pay close attention to the performance
In 2024, the centralized procurement of consumables will present a new pattern.
On May 20, the National Health Insurance Administration issued the "Notice of the Office of the National Health Security Administration on Strengthening Regional Coordination to Improve the Quality and Expansion of Centralized Pharmaceutical Procurement in 2024", which clearly stated:
Provincial alliance procurement should further strengthen the national coordination, and the conditions are upgraded to national alliance procurement, and the leading provinces should strengthen communication and coordination with the National Health Insurance Bureau, and invite all provinces to participate in the formation of a national alliance for centralized procurement.
The National Health Insurance Administration focuses on guiding the following national joint procurement work:
All provinces should pay close attention to "filling the gaps", and include the varieties that have been carried out in many provinces, such as hemostatic materials, patches, and in vitro diagnostic reagents, into the scope of centralized procurement through volume and price linkage. By the end of 2024, each province will complete at least one batch of centralized procurement of medical consumables.
The Notice of the National Medical Security Administration on Further Promoting the Experience of Sanming Medical Reform and Continuously Promoting the Innovation and Development of Medical Insurance Work also mentions:
Support and coordinate the provinces that are interested in taking the lead, with the participation of all provinces, to expand the scope of centralized procurement of drugs and medical consumables in a targeted manner, and to form a new pattern of centralized procurement of drugs and high-value medical consumables organized by the state, centralized procurement of drugs and high-value medical consumables led by the province, and centralized procurement at the provincial level as the supplement.
With the national tone, the number and coverage of consumables will be comprehensively upgraded. At the same time, based on the model of "centralized procurement in one place and follow-up in the whole country", the price difference of domestic centralized procurement consumables is expected to be flattened, and the cost of repeated bidding of enterprises can be reduced, and the operating efficiency of enterprises can be improved.
In addition, the National Health Insurance Administration mentioned in the notice that in 2024, it is necessary to further promote the centralized procurement of high-value medical consumables. In accordance with the principle of "one product, one policy", a new batch of high-value medical consumables organized by the state will be carried out in a timely manner; Carry out the nationwide unified procurement of artificial joints.
The footsteps of the fifth batch of consumables may be approaching.
The implementation mechanism of centralized procurement is also gradually improving. For example, focusing on the problem of drug and device payment that has accumulated for many years, the National Health Insurance Administration said that it encourages all provinces to actively explore and promote the direct settlement of medical insurance funds and pharmaceutical enterprises to purchase drug consumables. In addition, an online feedback mechanism will be established for the implementation of centralized procurement, to collect the supply and quality problems of the selected products reflected by medical institutions, as well as the problems of hospital admission and payment collection reflected by the selected enterprises, and guide the relevant provinces to deal with them in a timely manner.
In order to ensure the effectiveness of centralized procurement, the supervision of enterprise performance is becoming more and more refined.
Recently, the national procurement of artificial joints was opened in Tianjin. This successive procurement will take into account the performance of the first round of centralized procurement, and in terms of the ranking of the selected and the proportion of the volume, it will be inclined to enterprises with good performance, and enterprises with poor performance will be constrained.
Since June 1, Fujian Province has officially implemented the "Fujian Provincial Measures for the Management of the Supply and Performance of Drugs and Medical Consumables", and the performance of online enterprises and distribution enterprises will be assessed on a monthly basis.
Where there is a serious breach of contract by an enterprise or distribution enterprise, or if the breach of contract has a serious impact on the order of clinical diagnosis and treatment, it shall be suspended, cancelled from the relevant products of the production enterprise on the network, and disposed of according to the circumstances.
With the improvement of procurement, implementation and other rules, the influence of consumables centralized procurement will continue to expand, and more local brands are expected to get the opportunity to enter the hospital, which will help the performance growth and accelerate the domestic substitution process.